Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dexchlorpheniramine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sunburn.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 10, 2010
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Pharmacology/Toxicology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dexchlorpheniramine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Insect Bites and Stings.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
November 03, 2010
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Pharmacology/Toxicology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Dermatology
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dexchlorpheniramine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Sunburn.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 12, 2010
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Dermatology
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Dexchlorpheniramine is a Other Small Molecule drug candidate, which is currently being evaluated in phase III clinical studies for the treatment of Respiratory Tract Infections.
Product Name : Undisclosed
Product Type : Miscellaneous
Upfront Cash : Inapplicable
March 12, 2010
Lead Product(s) : Dexchloropheniramine Maleate
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase III
Sponsor : Undisclosed
Deal Size : Inapplicable
Deal Type : Inapplicable
Reset All
